SE447106B - PROCEDURE FOR PREPARING 10-OXO-10, 11-DIHYDRO-5H-DIBENS / B, F / AZEPIN-5-CARBOXAMIDE - Google Patents

PROCEDURE FOR PREPARING 10-OXO-10, 11-DIHYDRO-5H-DIBENS / B, F / AZEPIN-5-CARBOXAMIDE

Info

Publication number
SE447106B
SE447106B SE8007597A SE8007597A SE447106B SE 447106 B SE447106 B SE 447106B SE 8007597 A SE8007597 A SE 8007597A SE 8007597 A SE8007597 A SE 8007597A SE 447106 B SE447106 B SE 447106B
Authority
SE
Sweden
Prior art keywords
carboxamide
dihydro
oxo
procedure
dibens
Prior art date
Application number
SE8007597A
Other languages
Swedish (sv)
Other versions
SE8007597L (en
Inventor
J Gosteli
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE8007597L publication Critical patent/SE8007597L/en
Publication of SE447106B publication Critical patent/SE447106B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)

Description

10 15 20 -ZS 30 K3S 447 106 z Nackdelen med detta i och för sig redan omständliga förfa- rande för framställning av det erforderliga utgàngsmaterialet ligger i synnerhet i den relativt höga förbrukningen av brom, som uteslutande användes för införing och omvandling av funk- tionella grupper. 10 15 20 -ZS 30 K3S 447 106 z The disadvantage of this in itself already cumbersome procedure for the production of the required starting material lies in particular in the relatively high consumption of bromine, used exclusively for the introduction and transformation of national groups.

Dessa nackdelar undvikes i sammanhang med förfarandet en- ligt föreliggande uppfinning därigenom, att man använder det här- för erforderliga utgångsmaterialet, som framställes enligt den tyska Offenlegungsschrift 2 S42 335 antingen genom omsättning av S-acetyl-SH-dibensib,f7azepin med klor till 5-acetyl-10,11-diklor- -10,11-dihydro-SH-dibens[b,f7azepin, dess omvandling medelst en tertiär organisk bas, såsom diisopropyletylamín, till S-acety1- -10-klor-SH-dibens[b,f]azepin, följd av dess hydrolys medelst _ bromvätesyra till 10-kkn<5H-dibens[b,f7azepin, dess omsättning med fosgen till motsvarande 5-karbonylklorid och slutligen dess reaktion med ammoniak, eller genom addition av klor till 5H-di- bensßb,f7azepin-5-karboxamid och behandling av erhållen 10,11-di- klor-10,11-dihydro-SH-dibens¿b,f]azepin-S-karboxamid med en ter- tiär organisk bas, såsom 1,5-diazabicykloil.3.Q]non-5-en.These disadvantages are avoided in the context of the procedure the present invention by using the present invention. for the required starting material, which is prepared according to it German Offenlegungsschrift 2 S42 335 either by turnover of S-acetyl-SH-dibenzib, phazazepine with chlorine to 5-acetyl-10,11-dichloro- -10,11-dihydro-SH-dibenz [b, f7azepine, its conversion by a tertiary organic base, such as diisopropylethylamine, to S-acetyl- -10-chloro-SH-dibenz [b, f] azepine, followed by its hydrolysis by hydrobromic acid to 10-kkn <5H-dibenz [b, f7azepine, its turnover with phosgene to the corresponding 5-carbonyl chloride and finally its reaction with ammonia, or by adding chlorine to 5H-di- benzβ, f7azepine-5-carboxamide and treatment of obtained 10,11-di- chloro-10,11-dihydro-SH-dibenzob, f] azepine-S-carboxamide with a tertiary organic base, such as 1,5-diazabicycloyl.3.Q] non-5-ene.

Från Helv. chim. Acta, vol 55, s. 451-460 (1972) är en om- vandling av i metylenklorid löst 2-oxo-3-(2-nitro-3-klorfenyl)- -5-klor-5-hexensyraetylester medelst till -15°C kyld svavelsyra till 2,S-dioxo-3-(2-nitro-3-klorfenyl)-hexansyraetylester känd.From Helv. chim. Acta, vol 55, pp. 451-460 (1972) is a conversion of 2-oxo-3- (2-nitro-3-chlorophenyl) dissolved in methylene chloride - -5-chloro-5-hexenoic acid ethyl ester by means of sulfuric acid cooled to -15 ° C to 2,5-S-dioxo-3- (2-nitro-3-chlorophenyl) -hexanoic acid ethyl ester known.

I J. Amer. Chem. Soc. §§, 4290-91 (1966) har beskrivits ett enkelt förfarande för framställning av cykloalkanoner med olika ringstorlek, genom att i en tjänlig nukleofil förening ß-k1or- allylgruppen införes, vilken genom hydrolys medelst myrsyra eller 90-procentig svavelsyra omvandlas till motsvarande mättade keton.In J. Amer. Chem. Soc. §§, 4290-91 (1966) have described one simple process for the production of cycloalkanones with various ring size, by in a useful nucleophilic compound ß-chloro- the allyl group is introduced, which by hydrolysis by formic acid or 90% sulfuric acid is converted to the corresponding saturated ketone.

Sålunda omvandlas t.ex. 1-(2-klorallyl)-inden medelst 97-procen- tig myrsyra och därpå följande behandling med vatten till 3,S-(o- . -fenylen)-cyklohexanon. Beroende på det använda utgángsmaterialets struktur kan användningen av 90-procentig svavelsyra vid 0°C i stället för myrsyra vara fördelaktigare. Överraskande nog har det nu visat sig, att medelst förfa- randet enligt föreliggande uppfinning kan hydrolysen av 10-klor- -SH-dibens[b,f]azepin-5-karboxamid till 10-oxo-10,11-dihydro-5H-di- bensfib,f7azepin-5-karboxamid genomföras medelst koncentrerad svavelsyra vid normal temperatur. Med koncentrerad svavelsyra av- ses härvid en 90- till 96-procentig, företrädesvis en 96-procen- 10 15 20 25 30 35 40 s 447 106 tig svavelsyra. Reaktionstemperaturen ligger vid ca 10-30°C, före- trädesvis vid 1s-zs°c.Thus, e.g. 1- (2-chloroallyl) -indene by 97% formic acid and subsequent treatment with water to 3, S- (o-. -phenylene) -cyclohexanone. Depending on the starting material used structure, the use of 90% sulfuric acid at 0 ° C in instead of formic acid be more beneficial. Surprisingly, it has now been found that by means of according to the present invention, the hydrolysis of 10-chloro- -SH-dibenz [b, f] azepine-5-carboxamide to 10-oxo-10,11-dihydro-5H-di- benz fi b, f7azepine-5-carboxamide is carried out by concentrated sulfuric acid at normal temperature. With concentrated sulfuric acid a 90 to 96 percent, preferably a 96 percent 10 15 20 25 30 35 40 s 447 106 tig sulfuric acid. The reaction temperature is about 10-30 ° C, preferably typically at 1s-zs ° c.

Det kunde icke förväntas, att under betingelserna för för- farandet enligt föreliggande uppfinning karbamidgruppen icke skulle angrípas, enär det är känt, att karbamidföreningar hydro- lyseras genom vattenhaltiga syror, i synnerhet vid förhöjd tem- Peratur. Så är det från "Berfljme der Deutschen Chemischen Gesell- schaft" 2, s. 397 (1878) känt, att osymmetrisk difenylkarbamid vid uppvärmning med svavelsyra ger en blå lösning, som uppenbar- ligen förorsakas av difenylamin, enär enligt Merck Index, utgiven Rahway, N.J., U.S.A., 9, uppl. (1976), ger difenylamin med svavelsyra en djupblå färg.It could not be expected that under the conditions of the process of the present invention does not contain the urea group would be attacked, since it is known that urea compounds lysed by aqueous acids, especially at elevated temperatures Peratur. This is the case from "Ber fl jme der Deutschen Chemischen Gesell- schaft "2, p. 397 (1878) known, that asymmetric diphenylurea when heated with sulfuric acid gives a blue solution, which caused by diphenylamine, since according to the Merck Index, published Rahway, N.J., U.S.A., 9, ed. (1976), vol diphenylamine with sulfuric acid a deep blue color.

Det med det nya förfarandet uppnâeliga tekniska framsteget består vidare därvi, att hydrolysen enligt uppfinningen väsent- av Merck & Co., Inc. ligen sker vid rumstemperatur, varför faran för korrosionsskador på använda metalliska reaktionskärl förminskas, under det att det kända hydrolysförfarandet medelst mineralsyror sker vid åter- flödestemperatur, varigenom korrosionsbelastningen blir mycket förstorad.The technological progress achieved with the new procedure further consists in the fact that the hydrolysis according to the invention is essentially by Merck & Co., Inc. occurs at room temperature, hence the risk of corrosion damage on used metallic reaction vessels is reduced, while the known hydrolysis process by means of mineral acids takes place in flow temperature, whereby the corrosion load becomes high enlarged.

Däremot erhålles medelst förfarandet enligt uppfinningen 10-oxo-10,11-dihydro-SH-dibenslb,f7azepin-S-karboxamíden med ett utbyte av 64 % räknat på omsatt utgångsmaterial och med för- träfflig renhet.On the other hand, by means of the method according to the invention 10-oxo-10,11-dihydro-5H-dibenzyl, f7azepine-S-carboxamide with a yield of 64% calculated on the starting material traded and with polite purity.

Följande exempel åskådliggör förfarandet enligt uppfinningen.The following examples illustrate the process of the invention.

Temperaturerna anges i grader Celsius.Temperatures are given in degrees Celsius.

Exempel. I en genom ett med kalciumklorid fyllt torkrör förslu- ten rundkolv omröres en blandning av 0,5 g 10-klor-5H-dibens- Lb,f]azepin-5-karboxamid och S ml koncentrerad svavelsyra (96- procentig) under 10 min vid rumstemperatur, varpå en klar gul- aktig lösning erhålles. Omröringen fortsättes 76 h vid rums- temperatur, varvid en klar brun lösning erhålles. Reaktions- blandningen hälles på 100 g is och 100 ml metylenklorid, den organiska fasen separeras, den vattenhaltiga lösningen efter- tvättas 4 gånger med varje gång 80 ml metylenklorid, varpå de förenade organiska lösningarna (480 ml) tre gånger tvättas med halvmättad vattenhaltig natríumkloridlösning, torkas över natrium- sulfat och indunstas till torrhet under förminskat tryck. Åter- stoden omkristalliseras ur metylenklorid/eter, varefter erhålles ren 10-oxo-10,11-dihydro-SH-dibenslb,f]azepin-5-karboxamid med smältpunkten 213-215°C; utbyte räknat på omsatt utgångsmaterial: 64 % av teoretiskt utbyte.Example. In a drying tube filled with calcium chloride through a In a round flask, stir a mixture of 0.5 g of 10-chloro-5H-dibenzene Lb, f] azepine-5-carboxamide and 5 ml of concentrated sulfuric acid (96- percent) for 10 minutes at room temperature, after which a clear yellow such solution is obtained. Stirring is continued for 76 hours at room temperature. temperature, whereby a clear brown solution is obtained. Reactional the mixture is poured onto 100 g of ice and 100 ml of methylene chloride, the the organic phase is separated, the aqueous solution is washed 4 times with 80 ml of methylene chloride each time, then the combined organic solutions (480 ml) are washed three times with semi-saturated aqueous sodium chloride solution, dried over sodium sulfate and evaporated to dryness under reduced pressure. Re- the column is recrystallized from methylene chloride / ether, after which it is obtained pure 10-oxo-10,11-dihydro-5H-dibenzyl, f] azepine-5-carboxamide with mp 213-215 ° C; yield calculated on traded starting material: 64% of theoretical yield.

Claims (1)

447 106 Patentkrav Förfarande för framställning av 10-oxo-10,11-dihydro-5H- díbensfib,_tjazepín-5-karboxamíd med formeln I || n (I), CONH k ä n n e t e c k n a t därav, att man med 90-96-procentig svavelsyra vid en temperatur av H%$0°C hydrolyserar 10-k1or- SH-díbenslß,§]azepin-S-karboxamíd med formeln Cl I i íO\ !O;O\ ' ü (n) . Oš-x O <447 106 Patent claims Process for the preparation of 10-oxo-10,11-dihydro-5H-dibenz fib, thiazepine-5-carboxamide of the formula I || n (I), CONH is characterized in that with 90-96% sulfuric acid at a temperature of H% $ 0 ° C 10-chloro-SH-dibenzol íO \! O; O \ 'ü (n). Oš-x O <
SE8007597A 1979-10-30 1980-10-29 PROCEDURE FOR PREPARING 10-OXO-10, 11-DIHYDRO-5H-DIBENS / B, F / AZEPIN-5-CARBOXAMIDE SE447106B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH970479A CH642950A5 (en) 1979-10-30 1979-10-30 Process for the preparation of 10-oxo-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide

Publications (2)

Publication Number Publication Date
SE8007597L SE8007597L (en) 1981-05-01
SE447106B true SE447106B (en) 1986-10-27

Family

ID=4354741

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8007597A SE447106B (en) 1979-10-30 1980-10-29 PROCEDURE FOR PREPARING 10-OXO-10, 11-DIHYDRO-5H-DIBENS / B, F / AZEPIN-5-CARBOXAMIDE

Country Status (7)

Country Link
JP (1) JPS5673066A (en)
AT (1) AT375926B (en)
CH (1) CH642950A5 (en)
DK (1) DK457680A (en)
ES (1) ES8200097A1 (en)
NO (1) NO153368C (en)
SE (1) SE447106B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0112812D0 (en) * 2001-05-25 2001-07-18 Portela & Ca Sa Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom
GB2401605A (en) 2003-05-12 2004-11-17 Portela & Ca Sa Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide and optically enriched mixtures thereof
GB2422149A (en) 2005-01-14 2006-07-19 Portela & Ca Sa Process for the preparation of 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide
WO2007141798A1 (en) * 2006-06-07 2007-12-13 Jubilant Organosys Limited Process for producing oxcarbazepine via an 11-alkoxy-10-halo-dihydroiminostilbene intermediate

Also Published As

Publication number Publication date
NO153368C (en) 1986-03-05
ES496332A0 (en) 1981-10-16
ES8200097A1 (en) 1981-10-16
SE8007597L (en) 1981-05-01
JPS5673066A (en) 1981-06-17
CH642950A5 (en) 1984-05-15
ATA531980A (en) 1984-02-15
DK457680A (en) 1981-05-01
NO153368B (en) 1985-11-25
AT375926B (en) 1984-09-25
NO803229L (en) 1981-05-04

Similar Documents

Publication Publication Date Title
KR850000945B1 (en) Process for preparing 5-carbamoyl-10,11-dihydro-5h-dibenz(b,f)azepine
EP0003344A1 (en) Process for the preparation of fluor benzenes
Leuck et al. The mercuration of naphthalic acids
US3553224A (en) 1(2h)-pyridine-sulfonates
SE447106B (en) PROCEDURE FOR PREPARING 10-OXO-10, 11-DIHYDRO-5H-DIBENS / B, F / AZEPIN-5-CARBOXAMIDE
Fagan et al. Cycloadditions and other chemistry of 4-oxygenated pyrazoles
Kapovits et al. Diaryldiacyloxyspirosulfuranes—I: Syntheses from sulfides with halogenating agents
DE2825313C2 (en) Process for the preparation of thioindigo compounds
SU828963A3 (en) Method of preparing 10-cyano-5h-dibenz-(b,f)-azepin-5-carboxyamide
US4006170A (en) Process for the preparation of 1-aminoanthraquinone
JPS6087251A (en) Manufacture of substituted benzamide derivative
EP0368225B1 (en) Hydroxyl amine derivatives
US1765678A (en) Process for introducing sulphocyanic groups into organic compounds
US4196132A (en) Continuous flow process for the preparation of o-chloranil from tetrachlorocatechol
DE2353580C2 (en) Process for the preparation of o-acylamino-diaryl compounds
KR100486320B1 (en) Preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one
SU431163A1 (en) METHOD OF OBTAINING PyrILOCYANINES
EP1833814A2 (en) Method for the production of substituted 2-alkoxycarbonyl-3-aminothiophenes
FI64373B (en) FRAMEWORK FOR FRAMEWORK OF BASIC SUBSTITUTES ALKYLTEOFYLLINDERIVAT
AT239243B (en) Process for the preparation of 2, 3-dicyano-1, 4-dithia-anthrahydroquinone and -anthraquinone
DE2021706C2 (en) Process for the production of peptide-like ergot alkaloids
US1810009A (en) 4&#39;-sulpho-2-benzoyl-5-amino-benzoic acid
Hodgson et al. 171. Some derivatives of benz-1-thia-2: 3-diazole, the nature of the thiadiazole ring, and a note on the thiolation of 2-chloro-5-nitroaniline
DE1445547B2 (en) Process for the preparation of 3-amino-2,1-benzoisot triazoles
JPS61250060A (en) 2-benzylaminonaphthazarin and its preparation

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8007597-1

Effective date: 19880627

Format of ref document f/p: F